European Regimen Accelerator for Tuberculosis
Grant Agreement no. 853989 — ERA4TB
era4tb.org
Learn more through a webinar on 21 October 2025.
👉 Research paper: https://bit.ly/4q7jIKE
👉 Webinar registration: https://bit.ly/3VN3Sa5
Learn more through a webinar on 21 October 2025.
👉 Research paper: https://bit.ly/4q7jIKE
👉 Webinar registration: https://bit.ly/3VN3Sa5
🕒 Only one day left!
ERA4TB, in collaboration with @NICEComms and the @WHO, are proud to introduce our speakers for tomorrow's webinar!
Register to save your spot: tinyurl.com/ERA4TB
🕒 Only one day left!
ERA4TB, in collaboration with @NICEComms and the @WHO, are proud to introduce our speakers for tomorrow's webinar!
Register to save your spot: tinyurl.com/ERA4TB
🕒 Only two days left! Do not miss our online webinar, focusing on tackling anti-microbial resistance through policy and partnerships
Register here: tinyurl.com/ERA4TB
🕒 Only two days left! Do not miss our online webinar, focusing on tackling anti-microbial resistance through policy and partnerships
Register here: tinyurl.com/ERA4TB
One week left to register for our webinar on 'Innovating Access: Tackling Anti-Microbial Resistance Through Policy'.
📅 Date: 8 October 2025; 1-2pm UK time
💻 Register here: tinyurl.com/ERA4TB
One week left to register for our webinar on 'Innovating Access: Tackling Anti-Microbial Resistance Through Policy'.
📅 Date: 8 October 2025; 1-2pm UK time
💻 Register here: tinyurl.com/ERA4TB
#ERA4TB Consortium Members from University of Pavia, hosted an interactive stand at Sharper Night - European Researchers' Night (2025).
#ERA4TB Consortium Members from University of Pavia, hosted an interactive stand at Sharper Night - European Researchers' Night (2025).
How can health systems respond to #AMR through innovation & evidence-based policy? 🌍✨
🗓️ 8 Oct 2025 | 1–2pm UK | 2–3pm CEST
🎙️ Speakers from NICE & WHO
👉 Register: tinyurl.com/ERA4TB
@amr-accelerator.bsky.social @amr-accelerator.bsky.social @tballiance.bsky.social
How can health systems respond to #AMR through innovation & evidence-based policy? 🌍✨
🗓️ 8 Oct 2025 | 1–2pm UK | 2–3pm CEST
🎙️ Speakers from NICE & WHO
👉 Register: tinyurl.com/ERA4TB
@amr-accelerator.bsky.social @amr-accelerator.bsky.social @tballiance.bsky.social
How can health systems respond to #AMR through innovation & evidence-based policy? 🌍
Join our ERA4TB webinar
🗓️ 8 Oct 2025 | 1–2pm UK | 2–3pm CEST
🎙️ Speakers from @NICEComms & @WHO
👉 Register: tinyurl.com/ERA4TB
@amr-accelerator.bsky.social @who.int @nicecomms.bsky.social
How can health systems respond to #AMR through innovation & evidence-based policy? 🌍
Join our ERA4TB webinar
🗓️ 8 Oct 2025 | 1–2pm UK | 2–3pm CEST
🎙️ Speakers from @NICEComms & @WHO
👉 Register: tinyurl.com/ERA4TB
@amr-accelerator.bsky.social @who.int @nicecomms.bsky.social
👉 𝗥𝗲𝗮𝗱 𝗺𝗼𝗿𝗲: bit.ly/3VJJJBw
👉 𝗥𝗲𝗮𝗱 𝗺𝗼𝗿𝗲: bit.ly/3VJJJBw
#ERA4TB #TB #TranslationalResearch #DrugDevelopment
#ERA4TB #TB #TranslationalResearch #DrugDevelopment
Diana shared how ERA4TB has built a robust translational platform to accelerate the progression of anti-TB drug candidates and combinatorial regimens.
#TBSky #TBResearch #DrugDevelopment
Diana shared how ERA4TB has built a robust translational platform to accelerate the progression of anti-TB drug candidates and combinatorial regimens.
#TBSky #TBResearch #DrugDevelopment
#TBSky #TBResearch
#TBSky #TBResearch
www.page-meeting.org/default.asp?...
#TBSky #TBResearch #Tuberculosis
www.page-meeting.org/default.asp?...
#TBSky #TBResearch #Tuberculosis
🔬Keynotes on antimicrobial resistance & new TB medicine development
💊Progress on TBAJ-587
🔍Novel drug testing approaches & mechanisms of action
@ihieurope.bsky.social @amr-accelerator.bsky.social @www.unizar.es
🔬Keynotes on antimicrobial resistance & new TB medicine development
💊Progress on TBAJ-587
🔍Novel drug testing approaches & mechanisms of action
@ihieurope.bsky.social @amr-accelerator.bsky.social @www.unizar.es
Lindsay Sonnenkalb from @fzborstel.bsky.social will be speaking on ‘New technologies for understanding drug resistance’. 25 minute slots will be available throughout the day.
➡️Book here: www.leibniz-gemeinschaft.de/ueber-uns/ne...
#Tuberculosis #TBResearch #TBSky
Lindsay Sonnenkalb from @fzborstel.bsky.social will be speaking on ‘New technologies for understanding drug resistance’. 25 minute slots will be available throughout the day.
➡️Book here: www.leibniz-gemeinschaft.de/ueber-uns/ne...
#Tuberculosis #TBResearch #TBSky
@pasteurlille.bsky.social at the #EMBOcellBioHostPath conference in Blois (France) presenting the ERA4TB host-pathogen interaction platform (BT08) and enjoying vivid discussions with TB experts in the field.
#TBSky #TBResearch
@pasteurlille.bsky.social at the #EMBOcellBioHostPath conference in Blois (France) presenting the ERA4TB host-pathogen interaction platform (BT08) and enjoying vivid discussions with TB experts in the field.
#TBSky #TBResearch
Thanks to our host, @www.unizar.es, all our partners, our key-note speakers and the Scientific Advisory Board members for their attendance and insightful contributions.
@pasteur.fr @amr-accelerator.bsky.social @ihieurope.bsky.social
Thanks to our host, @www.unizar.es, all our partners, our key-note speakers and the Scientific Advisory Board members for their attendance and insightful contributions.
@pasteur.fr @amr-accelerator.bsky.social @ihieurope.bsky.social
"So what next, how do you take this outstanding drug discovery programme and make sure it is handed over to drug delivery and has the impact it deserves?"
Dr Francesca Conradie & Dr Gilla Kaplan, ERA4TB Scientific Advisory Board
#Tuberculosis #TBVaccines
"So what next, how do you take this outstanding drug discovery programme and make sure it is handed over to drug delivery and has the impact it deserves?"
Dr Francesca Conradie & Dr Gilla Kaplan, ERA4TB Scientific Advisory Board
#Tuberculosis #TBVaccines